Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

被引：0
|
作者：
Pei, Charles [1 ]
Blackburn, Lisa [2 ]
Sharma, Nidhi [3 ]
Bumma, Naresh [4 ]
Khan, Abdullah Mohammad [5 ]
Devarakonda, Srinivas [6 ]
Umyarova, Elvira [7 ]
Benson, Don [8 ]
Rosko, Ashley [9 ]
El Boghdadly, Zeinab [10 ]
Cottini, Francesca [9 ]
机构：
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Columbus, OH USA
[3] Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Ohio State Univ, Div Hematol, Columbus, OH USA
[6] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH USA
[7] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Hematol, Columbus, OH USA
[8] Ohio State Univ, Med Ctr, Columbus, OH USA
[9] Ohio State Univ, Columbus, OH USA
[10] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Infect Dis, Columbus, OH USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-201519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4717 / 4718
页数：2
相关论文
共 50 条
  • [1] Cytomegalovirus reactivation in patients with multiple myeloma
    Hasegawa, Tetsuo
    Aisa, Yoshinobu
    Shimazaki, Kengo
    Ito, Chisako
    Nakazato, Tomonori
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 78 - 82
  • [2] Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens
    De Novellis, Danilo
    Fontana, Raffaele
    Serio, Bianca
    Vaccaro, Emilia
    Guariglia, Roberto
    Morini, Denise
    Rizzo, Michela
    Giudice, Valentina
    Selleri, Carmine
    CANCER MEDICINE, 2024, 13 (14):
  • [3] Cytomegalovirus Reactivation during Elotuzumab Therapy in Patients with Multiple Myeloma
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Nomura-Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    ACTA HAEMATOLOGICA, 2024,
  • [4] Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents
    Naithani, R.
    Tarai, B.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (06) : 931 - 932
  • [5] Brazilian Relapsed Refractory Multiple Myeloma Patients Treated with Teclistamab Outside of Clinical Trials as an Expanded Access Program
    Pericole, Fernando
    Lima, Juliana Souza
    Ottoni, Erica
    Ribeiro, Glaciano
    Crusoe, Edvan de Queiroz
    Cunha, Rafael
    Costa, Abel
    Cury, Priscilla
    Maciel, James
    Hungria, Vania T. M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S196 - S197
  • [6] Clinical Factors Associated to VTE in Multiple Myeloma Patients Treated with Daratumumab
    Subramanian, Naveen G.
    Aung, Fleur M.
    Patel, Krina
    Lee, Hans C.
    Jin, Shida
    Young, Elliana
    Hernandez, Cristhiam Mauricio Rojas
    BLOOD, 2022, 140 : 5177 - 5179
  • [7] Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
    Tabata, Rikako
    Sato, Nobue
    Yamauchi, Nobuhiko
    Guo, Yong-Mei
    Nakamura, Hirotaka
    Nagata, Akihito
    Chi, Song-Gi
    Minami, Yosuke
    Yuda, Junichiro
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 465 - 467
  • [8] Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
    Rikako Tabata
    Nobue Sato
    Nobuhiko Yamauchi
    Yong-Mei Guo
    Hirotaka Nakamura
    Akihito Nagata
    Chi Song-Gi
    Yosuke Minami
    Junichiro Yuda
    Annals of Hematology, 2022, 101 : 465 - 467
  • [9] Teclistamab in patients with multiple myeloma and impaired renal function
    Joiner, Laura
    Bal, Susan
    Godby, Kelly N.
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (11) : E322 - E324
  • [10] Clinical characteristics and risk factors of infection in initially treated patients with multiple myeloma during the induction period
    Pan, Qianying
    Huang, Beihui
    Liu, Junru
    Chen, Meilan
    Gu, Jingli
    Kuang, Lifen
    Li, Xiaozhe
    Li, Juan
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (02)
12345